Susanne Bredenberg, CEO and board member, PhD (pharmacy), MBA, is an expert in pharmaceutics and has experience from drug development in the pharmaceutical industry.
Professor Håkan Engqvist, Board member, PhD (materials science), is an expert within the materials science fields, founder of several companies, e.g. OssDsign AB, Psilox AB.
Thomas Lundqvist, Chairman of the board, MSc Pharm, has founded several companies e.g. Orexo AB, Neopharma AB and Kineticon AB, has high knowledge within pharmacokinetics and regulatory affairs and has experience
from the pharmaceutical industry and medical products agency.